A. Progress has been made in decreasing VPD during the past 50 years B. Some progress has been made in decreasing VPD in limited areas, between 2011 and 2012 C. There is more work to be done to reduce the deaths caused by VPD D. All of the above

A. Being an immunization advocate B. Educating patients about vaccines C. Partnering with others to provide vaccines D. All of the above

A. New Varicella recommendations B. New Pneumococcal vaccine recommendations C. Haemophilus influenzae type B (HiB) bar added to the chart D. Additional influenza footnote added about recombinant influenza vaccine (RIV) and live-attenuated influenza vaccine (LAIV) for children 2 to 8 years of age

A. That only immunizing providers incorporate an immunization needs assessment into every clinical encounter B. That nonimmunizing providers refer patients with immunization needs to other providers and that they follow up to ensure the patient received the immunization C. That only immunizing providers understand how to access immunization information systems D. That nonimmunizing providers place information about immunizing providers in their practice sites

A. Surveys completed by both physicians and patients show their perceptions of vaccination discussions during clinic visits are very aligned B. Most adults are aware of their immunization needs across the majority of VPDs C. Adults often access vaccinations at places that are open in the evening and on weekends and holidays D. Tremendous progress has been made in reaching Healthy People 2020 immunization goals with few gaps remaining

A. History of severe allergic reaction to any vaccine component B. History of severe allergic reaction to gentamicin or gelatin C. Moderate or severe illness, with or without fever D. History of Guillain-Barré Syndrome within 6 weeks of previous vaccination

A. They should not be administered until 48 hours after antiviral therapy is discontinued B. Advisory Committee on Immunization Practices (ACIP) recommends persons with asthma and other chronic conditions be given the inactivated influenza vaccine (IIV) C. Adults aged ≥ 50 years should receive the IIV D. Post-vaccine administration, antiviral therapy agents should not be administered for 7 days

A. PCV13 only B. PPSV23 only C. PCV13 followed by PPSV23 6-12 months later D. PPSV23 followed by PCV13 one or more years later

A. They can administer immunizations pursuant to a prescriber protocol B. They can independently initiate and administer vaccines routinely recommended by the ACIP and the Centers for Disease Control and Prevention (CDC) C. They cannot independently initiate and administer Typhoid, Yellow Fever, Japanese Encephalitis, Rabies, or bacillus Calmette-Guérin (BCG) vaccines D. They must report vaccinations to the California Immunization Registry

A. There is a significant gap in pregnant women receiving Tdap (tetanus, diphtheria, and pertussis vaccine) during the 3rd trimester of pregnancy (77%) among mothers whose infants contracted pertussis B. Influenza vaccination rates among adults 18 to 64 years of age are more than 66% C. Influenza vaccination rates among adults 65 years of age and older are more than 70% D. Pediatric immunization rates across all VPDs are more than 80%